Suchen
eXoZymes Inc
EXOZZur Watchlist hinzufügen
8.575USD
+0.075+0.88%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
72.71MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über eXoZymes Inc Unternehmen
eXoZymes Inc, formerly Invizyne Technologies, Inc., is an artificial intelligence (AI) engineered enzyme that can transform sustainable feedstock into essential chemicals, medicines, and biofuels. The Company has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.
eXoZymes Inc Informationen
BörsenkürzelEXOZ
Name des UnternehmenseXoZymes Inc
IPO-datumNov 13, 2024
CEOHeltzen (Michael)
Anzahl der mitarbeiter31
WertpapierartOrdinary Share
GeschäftsjahresendeNov 13
Addresse750 Royal Oaks Dr
StadtMONROVIA
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl91016
Telefon16264151488
Websitehttps://exozymes.com/
BörsenkürzelEXOZ
IPO-datumNov 13, 2024
CEOHeltzen (Michael)
Führungskräfte von eXoZymes Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Paul Hideo Opgenorth, Ph.D.
Dr. Paul Hideo Opgenorth, Ph.D.
Vice President - Development
Vice President - Development
647.49K
+0.62%
Mr. Edgardo Rayo
Mr. Edgardo Rayo
Director
Director
77.91K
--
Mr. Fouad Nawaz
Mr. Fouad Nawaz
Vice President - Finance
Vice President - Finance
9.49K
+63.23%
Mr. Michael Heltzen
Mr. Michael Heltzen
Chief Executive Officer
Chief Executive Officer
--
-100.00%
Dr. Tyler Korman, Ph.D.
Dr. Tyler Korman, Ph.D.
Vice President - Research
Vice President - Research
--
--
Mr. Christopher A. (Chris) Marlett
Mr. Christopher A. (Chris) Marlett
Chairman of the Board
Chairman of the Board
--
--
Mr. Anthony DiGiandomenico
Mr. Anthony DiGiandomenico
Director
Director
--
--
Dr. James U. Bowie, Ph.D.
Dr. James U. Bowie, Ph.D.
Independent Director
Independent Director
--
--
Dr. James J. (Jim) Lalonde, Ph.D.
Dr. James J. (Jim) Lalonde, Ph.D.
Independent Director
Independent Director
--
--
Dr. Lon Edward Bell, Ph.D.
Dr. Lon Edward Bell, Ph.D.
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Paul Hideo Opgenorth, Ph.D.
Dr. Paul Hideo Opgenorth, Ph.D.
Vice President - Development
Vice President - Development
647.49K
+0.62%
Mr. Edgardo Rayo
Mr. Edgardo Rayo
Director
Director
77.91K
--
Mr. Fouad Nawaz
Mr. Fouad Nawaz
Vice President - Finance
Vice President - Finance
9.49K
+63.23%
Mr. Michael Heltzen
Mr. Michael Heltzen
Chief Executive Officer
Chief Executive Officer
--
-100.00%
Dr. Tyler Korman, Ph.D.
Dr. Tyler Korman, Ph.D.
Vice President - Research
Vice President - Research
--
--
Mr. Christopher A. (Chris) Marlett
Mr. Christopher A. (Chris) Marlett
Chairman of the Board
Chairman of the Board
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von eXoZymes Inc?
Die fünf größten Anteilseigner von eXoZymes Inc sind: Dr. Paul Hideo Opgenorth, Ph.D.
Wie viele Institutionen halten Anteile an eXoZymes Inc (EXOZ)?
Mit Stand vom 2026Q1 halten 13 Institutionen Anteile an eXoZymes Inc, mit einem Gesamtmarktwert von etwa 94.24K, was 1.11% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 16676.00 gestiegen.